Article
Identification of hub genes involved in cisplatin resistance in head and neck cancer
30 Jan 2023
Abstract excerpt
BACKGROUND: Cisplatin resistance is one of the major contributors to the poor survival rate among head and neck cancer (HNC) patients. Focusing on the protein-protein interaction rather than a single protein could provide a better understanding of drug resistance. Thus, this study aimed to identify hub genes in a complex network of cisplatin resistance associated genes in HNC chemotherapy via a series of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
